Since EDA began accepting applications to that program last July, 30 investments have been approved for a total of $14.7 million. Businesses that benefitted in the first quarter of 2014 include:

Bat Blue Networks, a provider of cloud-based virtual perimeter services, based in Clifton
VectraCor, a Totowa-based company working to develop and commercialize products to simplify and speed up diagnosis, prevention, and treatment of cardiac and neurological diseases.

At the meeting, the EDA also got an update on its Commercialization Center for Innovative Technologies, which is part of the Technology Centre of New Jersey campus in North Brunswick. In the first quarter, three new tenants arrived at CCIT:

Novanex, a medical device company that develops and commercializes innovative devices and technology to monitor or detect disease conditions or status
VClinBio, a scientific research organization that provides services for advancing drug discovery, personalized therapeutics, biomarkers research and clinical diagnostics validation
Crystal Pharmatech, a technology-driven contract research organization that focuses on materials science and engineering for drug development.

Also, specialty pharmaceutical company Ascendia Pharmaceuticals took an additional 1,000 square feet of space at the center.

Instant Insights /

Bonus Tax Breaks Go to Manufacturing, Tech Cos.

Related Stories

Recommended For You